Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?

Guo Yan Liu, Wei Zhang

Research output: Contribution to journal › Editorial › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?'. Together they form a unique fingerprint.

Medicine & Life Sciences